Podcasts

Podcast: Profs Nicholls, Nissen and Zoungas on emerging approaches to CV risk reduction

Wednesday, 13 May 2020


In this episode endocrinologist Professor Sophia Zoungas, Head of Monash University’s School of Public Health and Preventive Medicine, talks to the panel about how concerns around safety of an approved agent in the diabetes space over two decades has ultimately led to more data and increased confidence in prescribing today.

This is an excerpt from a recent Amgen One Cardiovascular Academy live webcast, hosted by Professor Stephen Nicholls (MonashHeart), in conversation with Professor Steven Nissen (The Cleveland Clinic, Ohio, USA) and Professor Sophia Zoungas (Head of Monash University’s School of Public Health and Preventive Medicine).


the limbic · CV risk reduction: current status and future directions
Amgen One Cardiovascular Academy educational agenda is developed by an independent steering committee comprising Professor Stephen Nicholls, MonashHeart, VIC (Chair), Professor Gemma Figtree, Royal North Shore Hospital, NSW, Professor Anthony Keech, Royal Prince Alfred Hospital, NSW, Professor Karam Kostner, Mater Hospital, QLD, Professor Richard O’Brien, Austin Hospital, VIC, Associate Professor David Sullivan, Royal Prince Alfred Hospital, NSW, Professor Gerald Watts, University of Western Australia, WA and Professor Sophia Zoungas, Monash University, VIC.

Already a member?

Login to keep reading.

OR
Email me a login link
logo

© 2022 the limbic